Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Therapeutics - Page 16

Therapeutics

FDA approved Xolair as first and only medicine for children and adults with one or more food allergies
Biotechnology | Disease | FDA | Therapeutics

FDA approved Xolair as first and only medicine for children and adults with one or more food allergies

On Feb. 16. 2024, Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Xolair…

Read More FDA approved Xolair as first and only medicine for children and adults with one or more food allergiesContinue

European Commission approved first CRISPR/Cas9 gene-edited therapy, CASGEVY for reatment of SCD and TDT
Biotechnology | CRISPR | Stem Cell | Therapeutics

European Commission approved first CRISPR/Cas9 gene-edited therapy, CASGEVY for reatment of SCD and TDT

On Feb. 13, 2024, CRISPR Therapeutics announced that the European Commission had granted conditional marketing authorization to CASGEVY…

Read More European Commission approved first CRISPR/Cas9 gene-edited therapy, CASGEVY for reatment of SCD and TDTContinue

Alaska Department of Health confirmed first fatal case of Alaskapox virus
Biotechnology | Infectious Disease | Medicine | Non-Profit Research | Therapeutics

Alaska Department of Health confirmed first fatal case of Alaskapox virus

On Feb. 9, 2024, the state of Alaska Department of Health Alaska Department of Health confirmed the first…

Read More Alaska Department of Health confirmed first fatal case of Alaskapox virusContinue

China builds world’s most detailed human genome with ‘enormous’ implications for disease treatment
Biotechnology | Diagnostics | Disease | Genomics | Therapeutics

China builds world’s most detailed human genome with ‘enormous’ implications for disease treatment

On Feb. 2, 2024, Chinese scientists announced they have assembled the world’s most detailed human genome yet, a…

Read More China builds world’s most detailed human genome with ‘enormous’ implications for disease treatmentContinue

Washington University’s Jeffrey T. Fort Neuroscience Research building dedicated
Biotechnology | COVID-19 | Diagnostics | Disease | Neurology | Therapeutics

Washington University’s Jeffrey T. Fort Neuroscience Research building dedicated

On Jan. 25, 2024, dozens of noted scientists, philanthropists, and Washington University, state and local leaders celebrated the…

Read More Washington University’s Jeffrey T. Fort Neuroscience Research building dedicatedContinue

Small robot made big difference for cochlear implant patient at Oregon Health & Science University
Biotechnology | Diagnostics | Disease | Medical Device | Non-Profit Research | Therapeutics

Small robot made big difference for cochlear implant patient at Oregon Health & Science University

On Jan. 24, 2024, Oregon Health & Science University announced that Pamela Runner, 77, of Corvallis, became the…

Read More Small robot made big difference for cochlear implant patient at Oregon Health & Science UniversityContinue

CRISPR Therapeutics announced FDA approval of CASGEVY for treatment of ransfusion-dependent beta thalassemia
Biotechnology | CRISPR | Disease | FDA | Therapeutics

CRISPR Therapeutics announced FDA approval of CASGEVY for treatment of ransfusion-dependent beta thalassemia

On Jan. 16, 2024, the U.S. Food and Drug Administration (FDA) announced it had approved CRISPR Therapeutics’ CASGEVY…

Read More CRISPR Therapeutics announced FDA approval of CASGEVY for treatment of ransfusion-dependent beta thalassemiaContinue

Swissmedic Authorises CSL’s HEMGENIX® (etranacogene dezaparvovec) as First Gene Therapy for Hemophilia B
Biotechnology | Disease | FDA | Therapeutics

Swissmedic Authorises CSL’s HEMGENIX® (etranacogene dezaparvovec) as First Gene Therapy for Hemophilia B

On Jan. 15, 2024, CSL announced that Swissmedic had authorised HEMGENIX® (etranacogene dezaparvovec), the first and currently only gene…

Read More Swissmedic Authorises CSL’s HEMGENIX® (etranacogene dezaparvovec) as First Gene Therapy for Hemophilia BContinue

NIH-supported researchers created single-cell atlas of the placenta during term labor
Biotechnology | Diagnostics | Disease | NIH | Therapeutics | Women's Health

NIH-supported researchers created single-cell atlas of the placenta during term labor

On Jan. 10, 2024, an National Institutes of Health (NIH) supported study announced an n atlas revealing the…

Read More NIH-supported researchers created single-cell atlas of the placenta during term laborContinue

‘LEQEMBI’ (Lecanemab) approved for treatment of Alzheimer’s disease in China
Biotechnology | Disease | Neurology | Therapeutics

‘LEQEMBI’ (Lecanemab) approved for treatment of Alzheimer’s disease in China

On Jan. 9, 2024, Biogen and Eisai announced that humanized anti- soluble aggregated amyloid-beta (Aβ) monoclonal antibody ‘LEQEMBI’…

Read More ‘LEQEMBI’ (Lecanemab) approved for treatment of Alzheimer’s disease in ChinaContinue

Molecular jackhammers’ ‘good vibrations’ eradicate cancer cells
Biotechnology | Diagnostics | Medical Device | Oncology | Therapeutics

Molecular jackhammers’ ‘good vibrations’ eradicate cancer cells

On Dec. 19, 2023, a research team led by Rice University reported they found that the atoms of…

Read More Molecular jackhammers’ ‘good vibrations’ eradicate cancer cellsContinue

PNNL created Center for Artificial Intelligence
Artificial Intelligence | Biotechnology | Diagnostics | Disease | Non-Profit Research | Therapeutics

PNNL created Center for Artificial Intelligence

On Dec. 14, 2023, the Department of Energy’s Pacific Northwest National Laboratory announced that it had created the…

Read More PNNL created Center for Artificial IntelligenceContinue

Alberta researchers revealed full structure of ‘ancient genetic parasite’ implicated in human diseases
Biotechnology | Diagnostics | Disease | Genomics | Neurology | Therapeutics

Alberta researchers revealed full structure of ‘ancient genetic parasite’ implicated in human diseases

On Dec. 14, 2023, the University of Alberta announced that a study published in Nature sheds light on…

Read More Alberta researchers revealed full structure of ‘ancient genetic parasite’ implicated in human diseasesContinue

ZURZUVAE (zuranolone) CIV, a landmark treatment for women with postpartum Depression, available in the U.S.
Biotechnology | Life Science History | Medicine | Therapeutics

ZURZUVAE (zuranolone) CIV, a landmark treatment for women with postpartum Depression, available in the U.S.

On Dec. 14, 2023, Biogen and Sage Therapeutics announced ZURZUVAE (zuranolone) 50 mg (two 25 mg capsules per…

Read More ZURZUVAE (zuranolone) CIV, a landmark treatment for women with postpartum Depression, available in the U.S.Continue

Scientists unveiled complete cell map of a whole mammalian brain
Biotechnology | Diagnostics | Disease | NIH | Therapeutics

Scientists unveiled complete cell map of a whole mammalian brain

On Dec. 13, 2023, for the first time ever, an international team of researchers announced they had created…

Read More Scientists unveiled complete cell map of a whole mammalian brainContinue

FDA approved first gene therapies to treat patients with sickle cell disease
CRISPR | Genomics | Stem Cell | Therapeutics

FDA approved first gene therapies to treat patients with sickle cell disease

On Dec. 8, 2023, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing…

Read More FDA approved first gene therapies to treat patients with sickle cell diseaseContinue

Vertex and CRISPR Therapeutics announced U.S. FDA approval of CASGEVY for treatment of sickle Cell disease
Biotechnology | CRISPR | FDA | Genomics | Therapeutics

Vertex and CRISPR Therapeutics announced U.S. FDA approval of CASGEVY for treatment of sickle Cell disease

On Dec. 8, 2023, Vertex Pharmaceuticals and CRISPR Therapeutics announced that the U.S. Food and Drug Administration (FDA)…

Read More Vertex and CRISPR Therapeutics announced U.S. FDA approval of CASGEVY for treatment of sickle Cell diseaseContinue

bluebird bio announced commercial launch of LYFGENIA’ gene therapy for patients ages 12 and older with sickle cell disease
Biotechnology | FDA | Therapeutics

bluebird bio announced commercial launch of LYFGENIA’ gene therapy for patients ages 12 and older with sickle cell disease

On Dec. 8, 2023, bluebird bio announced the U.S. commercial launch of its LYFGENIA’ (lovotibeglogene autotemcel, also known…

Read More bluebird bio announced commercial launch of LYFGENIA’ gene therapy for patients ages 12 and older with sickle cell diseaseContinue

University of Wisconsin-Madison sewer sleuthing, air vacuuming scientists keep tabs on COVID-19
COVID-19 | Non-Profit Research | Therapeutics

University of Wisconsin-Madison sewer sleuthing, air vacuuming scientists keep tabs on COVID-19

On Dec. 4 2023, the University of Wisconsin-Madison researchers announced that while analyzing data from wastewater samples collected…

Read More University of Wisconsin-Madison sewer sleuthing, air vacuuming scientists keep tabs on COVID-19Continue

World’s largest genetic project unveiled incredible new data
Biotechnology | Diagnostics | Disease | Genomics | Neurology | Oncology | Therapeutics

World’s largest genetic project unveiled incredible new data

On Nov. 30, 2023, in a momentous landmark for medical research, UK Biobank announced that it had unveiled…

Read More World’s largest genetic project unveiled incredible new dataContinue

Vertex and CRISPR Therapeutics announced authorization of first CRISPR/Cas9 gene-edited therapy by UK MHRA for treatment of Sickle Cell Disease
Biotechnology | CRISPR | Therapeutics

Vertex and CRISPR Therapeutics announced authorization of first CRISPR/Cas9 gene-edited therapy by UK MHRA for treatment of Sickle Cell Disease

On Nov. 16, 2023, Vertex and CRISPR Therapeutics announced that the United Kingdom (U.K.) Medicines and Healthcare products…

Read More Vertex and CRISPR Therapeutics announced authorization of first CRISPR/Cas9 gene-edited therapy by UK MHRA for treatment of Sickle Cell DiseaseContinue

CPRIT invested $63 million to bring innovative researchers and companies to Texas
Biotechnology | Diagnostics | Non-Profit Research | Oncology | Therapeutics | Vaccine

CPRIT invested $63 million to bring innovative researchers and companies to Texas

On Nov. 15, 2023, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it had approved…

Read More CPRIT invested $63 million to bring innovative researchers and companies to TexasContinue

WHO reported Marburg virus disease outbreak in Equatorial Guinea
Biotechnology | Diagnostics | Infectious Disease | Therapeutics

WHO reported Marburg virus disease outbreak in Equatorial Guinea

On Nov. 13, 2023, the World Health Organization (WHO announced that the Ministry of Health and Social Welfare…

Read More WHO reported Marburg virus disease outbreak in Equatorial GuineaContinue

The White House lanuched Initiative on Women’s Health Research
Disease | Medicine | Oncology | Therapeutics | Women's Health

The White House lanuched Initiative on Women’s Health Research

On Nov. 13, 2023, the White House announced the first-ever Initiative on Womenメs Health Research, an effort led…

Read More The White House lanuched Initiative on Women’s Health ResearchContinue

Surgeons in New York announced world’s first eye transplant
Biotechnology | Non-Profit Research | Therapeutics

Surgeons in New York announced world’s first eye transplant

On Nov. 10, 2023, surgeons in New York announced they had performed the first-ever whole-eye transplant in a…

Read More Surgeons in New York announced world’s first eye transplantContinue

First locally acquired case of dengue in California detected in a Pasadena resident
Biotechnology | Infectious Disease | Therapeutics

First locally acquired case of dengue in California detected in a Pasadena resident

On Oct. 30, 2023,California Department of Public Health reported The first locally acquired case of dengue in California…

Read More First locally acquired case of dengue in California detected in a Pasadena residentContinue

California’s Stem Cell Agency invested more than $42.1 million in translational-stage research
Biotechnology | Diagnostics | Medical Device | Neurology | Non-Profit Research | Stem Cell | Therapeutics

California’s Stem Cell Agency invested more than $42.1 million in translational-stage research

On Oct. 27, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $42.1 million to fund various translational…

Read More California’s Stem Cell Agency invested more than $42.1 million in translational-stage researchContinue

U.S. CDC reported high rates of child flu hospitalizations recorded in 2022-2023 season
Biotechnology | Diagnostics | Infectious Disease | Influenza | Therapeutics | Vaccine

U.S. CDC reported high rates of child flu hospitalizations recorded in 2022-2023 season

On Oct. 20, 2023, the U.S. Centers for Disease Control and Prevention (CDC) reported that among children and…

Read More U.S. CDC reported high rates of child flu hospitalizations recorded in 2022-2023 seasonContinue

Purdue nameed new pediatric cancer research center for the late Tyler Trent
Biotechnology | Diagnostics | Oncology | Therapeutics

Purdue nameed new pediatric cancer research center for the late Tyler Trent

On Oct. 14, 2023, Purdue University ensured that the memory of the former graduate and devoted Boilermaker football…

Read More Purdue nameed new pediatric cancer research center for the late Tyler TrentContinue

California’s Stem Cell Agency approved $110 million investment into basic research in neuropsychiatric diseases
Biotechnology | Diagnostics | Disease | Neurology | Stem Cell | Therapeutics

California’s Stem Cell Agency approved $110 million investment into basic research in neuropsychiatric diseases

On Oct. 2, 2023, the California Institute for Regenerative Medicine (CIRM) announced its approval of a new program…

Read More California’s Stem Cell Agency approved $110 million investment into basic research in neuropsychiatric diseasesContinue

Page navigation

Previous PagePrevious 1 … 14 15 16 17 18 … 106 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search